Alimera Sciences (ALIM) Misses Q4 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SPY
9. SWKS
10. FISV

Go back to Alimera Sciences (ALIM) Misses Q4 EPS by 3c

Alimera Sciences Reports Record Fourth Quarter and Full Year 2016 Financial Results

March 1, 2017 4:00 PM EST

Fourth Quarter and Full Year Ended 2016 Highlights

Annual revenue increased 53% for 2016 compared to 2015Record fourth quarter 2016 revenue of $10.7 million represents an 84% increase over fourth quarter 2015Alimera expects its distributors in Italy and the Middle East to further the availability of ILUVIEN in 2017Alimera to host conference call on March 2, 2017 at 10:00 AM ET

ATLANTA, March 01, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a global pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic... More